Monolayer-capped gold nanoparticles for disease detection from breath

References

• 1 Haick H, Broza YY, Mochalski P, Ruzsanyi V, Amann A. Assessment, origin, and implementation of breath volatile cancer markers. Chem. Soc. Rev. 43, 1423–1449 (2014).
  Medline CASGoogle Scholar
• 2 Amann A, Mochalski P, Ruzsanyi V, Broza YY, Haick H. Assessment of the exhalation kinetics of volatile cancer biomarkers based on their physicochemical properties. J. Breath Res. 8(1), 016003 (2014).
  Medline CASGoogle Scholar
• 3 Konvalina G, Haick H. Sensors for breath testing: from nanomaterials to comprehensive disease detection. Acc. Chem. Res. 47, 66–76 (2014).
  Medline CASGoogle Scholar
• 4 Broza YY, Haick H. Nanomaterial-based sensors for detection of disease by volatile organic compounds. Nanomedicine (Lond.) 8, 785–806 (2013).
  CASGoogle Scholar
• 5 Amann A, Corradi M, Mazzone P, Mutti A. Lung cancer biomarkers in exhaled breath. Expert Rev. Mol. Diagn. 11, 207–217 (2011).
  Medline CASGoogle Scholar
• 6 Tisch U, Haick H. Arrays of chemisensitive monolayer-capped metallic nanoparticles for diagnostic breath testing. Rev. Chem. Eng. 26, 171–179 (2010).
  CASGoogle Scholar
• 7 Hakim M, Broza Y, Barash O et al. Volatile organic compounds of lung cancer and possible biochemical pathways. Chem. Rev. 112, 5949–5966 (2012).
  Medline CASGoogle Scholar
• 8 Peng G, Hakim M, Broza YY et al. Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br. J. Cancer 103, 542–551 (2010).
  Medline CASGoogle Scholar
• 9 Miekisch W, Schubert JK, Noeldge-Schomburg GFE. Diagnostic potential of breath analysis – focus on volatile organic compounds. Clin. Chim. Acta 347, 25–39 (2004).
  Medline CASGoogle Scholar
• 10 Amann A, Ligor M, Ligor T et al. Analysis of exhaled breath for screening of lung cancer patients. Memo 3, 106–112 (2010).
  Google Scholar
• 11 Peng G, Tisch U, Adams O et al. Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat. Nanotechol. 4, 669–673 (2009).
  Medline CASGoogle Scholar
• 12 Phillips M, Basa-Dalay V, Bothamley G et al. Breath biomarkers of active pulmonary tuberculosis. Tuberculosis (Edinb.) 90, 145–151 (2010).
  Medline CASGoogle Scholar
• 13 Phillips M, Cataneo RN, Cummin ARC et al. Detection of lung cancer with volatile markers in the breath. Chest 123, 2115–2123 (2003).
  Medline CASGoogle Scholar
• 14 Xu ZQ, Broza YY, Ionsecu R et al. The breathprints of gastric cancer and benign gastric conditions. Br. J. Cancer 108, 941–950 (2012).
  Google Scholar
• 15 Paska YS, Stelzner T, Tisch U, Assad O, Christiansen S, Haick H. Molecular gating of silicon nanowire field effect transistors with nonpolar analytes. ACS Nano 6, 335–345 (2012).
  Medline CASGoogle Scholar
• 16 Konvalina G, Haick H. The effect of humidity on nanoparticle-based chemiresistors: a comparison between synthetic and real-world samples. ACS Appl. Mater. Interf. 4, 317–325 (2012).
  Medline CASGoogle Scholar
• 17 Paska Y, Haick H. Interactive effect of hysteresis and surface chemistry on gated silicon nanowire gas sensors. ACS Appl. Mater. Interf. 4, 2604–2617 (2012).
  Medline CASGoogle Scholar
• 18 Assady S, Marom O, Hemli M et al. Impact of hemodialysis on exhaled volatile organic compounds in end-stage renal disease: a pilot study. Nanomedicine (Lond.) 9(7), 1035–1045 (2014).
  CASGoogle Scholar
• 19 Paska Y, Stelzner T, Christiansen S, Haick H. Enhanced sensing of nonpolar volatile organic compounds by silicon nanowire field effect transistors. ACS Nano 5, 5620–5626 (2011).
  Medline CASGoogle Scholar
• 20 Chen CY, Kuo YT, Lee CH et al. Differentiation between malignant and benign gastric ulcers: CT virtual gastroscopy versus optical gastroendoscopy. Radiology 252, 410–417 (2009).
  MedlineGoogle Scholar
• 21 Zilberman Y, Ionescu R, Feng X, Mullen K, Haick H. Nanoarray of polycyclic aromatic hydrocarbons and carbon nanotubes for accurate and predictive detection in real-world environmental humidity. ACS Nano 5, 6743–6753 (2011).
  Medline CASGoogle Scholar
• 22 Zilberman Y, Tisch U, Shuster G et al. Carbon nanotube/hexa-peri-hexabenzocoronene bilayers for discrimination between nonpolar volatile organic compounds of cancer and humid atmospheres. Adv. Mater. 22, 4317–4320 (2010).
  Medline CASGoogle Scholar
• 23 Ionescu R, Broza Y, Shaltieli H et al. Detection of multiple sclerosis from exhaled breath using bilayers of polycyclic aromatic hydrocarbons and single-wall carbon nanotubes. ACS Chem. Neurosci. 2, 687–693 (2011).
  Medline CASGoogle Scholar
• 24 Peng G, Tisch U, Haick H. Detection of nonpolar molecules by means of carrier scattering in random networks of carbon nanotubes: toward diagnosis of diseases via breath samples. Nano Lett. 9, 1362–1368 (2009).
  Medline CASGoogle Scholar
• 25 Peng G, Trock E, Haick H. Detecting simulated patterns of lung cancer biomarkers by random network of single-walled carbon nanotubes coated with non-polymeric organic materials. Nano Lett. 8, 3631–3635 (2008).
  Medline CASGoogle Scholar
• 26 Wallis RS, Pai M, Menzies D et al. Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 375, 1920–1937 (2010).
  Medline CASGoogle Scholar
• 27 Daniel MC, Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 104, 293–346 (2004).
  Medline CASGoogle Scholar
• 28 Haick H. Chemical sensors based on molecularly modified metallic nanoparticles. J. Phys. D 40, 7173–7186 (2007).
  CASGoogle Scholar
• 29 Dovgolevsky E, Konvalina G, Tisch U, Haick H. Monolayer-capped cubic platinum nanoparticles for sensing nonpolar analytes in highly humid atmospheres. J. Phys. Chem. C 114, 14042–14049 (2010).
  CASGoogle Scholar
• 30 Dovgolevsky E, Tisch U, Haick H. Chemically sensitive resistors based on monolayer-capped cubic nanoparticles: towards configurable nanoporous sensors. Small 5, 1158–1161 (2009).
  Medline CASGoogle Scholar
• 31 Dovgolevsky E, Haick H. Direct observation of the transition point between quasi-spherical and cubic nanoparticles in two-step seed-mediated growth method. Small 4, 2059–2066 (2008).
  Medline CASGoogle Scholar
• 32 Segev-Bar M, Shuster G, Haick H. The effect of perforation on the sensing properties of monolayer-capped metallic nanoparticle films. J. Phys. Chem. C 116, 15361–15368 (2012).
  CASGoogle Scholar
• 33 Thaler ER, Hanson CW. Medical applications of electronic nose technology. Expert Rev. Med. Dev. 2, 559–566 (2005).
  MedlineGoogle Scholar
• 34 Tisch U, Haick H. Nanomaterials for cross-reactive sensor arrays. MRS Bull. 35, 797–803 (2010).
  CASGoogle Scholar
• 35 Joseph Y, Guse B, Vossmeyer T, Yasudaa A. Gold nanoparticle/organic networks as chemiresistor coatings: the effect of film morphology on vapor sensitivity. J. Phys. Chem. C 112, 12507–12514 (2008).
  CASGoogle Scholar
• 36 Goepel W. Chemical sensing, molecular electronics and nanotechnology: interface technologies down to the molecular scale. Sens. Actuat. B 4, 7–21 (1991).
  CASGoogle Scholar
• 37 Rock F, Barsan N, Weimar U. Electronic nose: current status and future trends. Chem. Rev. 108, 705–725 (2008).
  MedlineGoogle Scholar
• 38 Hu WT, Chen-Plotkin A, Arnold SE et al. Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease. Acta Neuropathol. 120, 385–399 (2010).
  MedlineGoogle Scholar
• 39 Schrag A, Ben-Shlomo Y, Quinn N. How valid is the clinical diagnosis of Parkinson's disease in the community? J. Neurol. Neurosurg. Psychiatry 73, 529–534 (2002).
  Medline CASGoogle Scholar
• 40 Tisch U, Schlesinger I, Ionescu R et al. Detection of Alzheimer's and Parkinson's disease from exhaled breath using nanomaterial-based sensors. Nanomedicine (Lond.) 8, 43–56 (2012).
  Google Scholar
• 41 Marom O, Nakhoul F, Tisch U, Shiban A, Abassi Z, Haick H. Gold nanoparticle sensors for detecting chronic kidney disease and disease progression. Nanomedicine (Lond.) 7, 639–650 (2012).
  CASGoogle Scholar
• 42 Nakhleh MK, Amal H, Awad A et al. Sensor arrays based on nanoparticles for early detection of kidney injury by breath samples. Nanomedicine doi:10.1016/j.nano.2014.06.007 (2014) (Epub ahead of print).
  MedlineGoogle Scholar
• 43 Nakhleh MK, Jeries R, Gharra A et al. Detecting active pulmonary tuberculosis with a breath test using nanomaterial-based sensors. Eur. Respir. J. 43, 1522–1525 (2014).
  MedlineGoogle Scholar
• 44 Peled N, Hakim M, BunnPAJr et al. Non-invasive breath analysis of pulmonary nodules. J. Thorac. Oncol. 7, 1528–1533 (2012).
  MedlineGoogle Scholar
• 45 Broza YY, Kremer R, Tisch U et al. A nanomaterial-based breath test for short-term follow-up after lung tumor resection. Nanomedicine 9, 15–21 (2012).
  MedlineGoogle Scholar
• 46 Moran SM, Myers BD. Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int. 27, 928–937 (1985).
  Medline CASGoogle Scholar
• 47 Devarajan P. Review: neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Nephrology 15, 419–428 (2010).
  MedlineGoogle Scholar
• 48 Malyszko J. Biomarkers of acute kidney injury in different clinical settings: a time to change the paradigm? Kidney Blood Press. Res. 33(5), 368–382 (2010).
  Medline CASGoogle Scholar
• 49 Cohen-Kaminsky S, Nakhleh M, Perros F et al. A proof of concept for the detection and classification of pulmonary arterial hypertension through breath analysis with a sensor array. Am. J. Respir. Crit. Care Med. 188, 756–759 (2013).
  MedlineGoogle Scholar
• 50 Lobue PA, Enarson DA, Thoen TC. Tuberculosis in humans and its epidemiology, diagnosis and treatment in the United States. Int. J. Tuberc. Lung Dis. 14, 1226–1232 (2010).
  Medline CASGoogle Scholar
• 51 Syhre M, Chambers ST. The scent of Mycobacterium tuberculosis. Tuberculosis (Edinb.) 88, 317–323 (2008).
  Medline CASGoogle Scholar
• 52 Syhre M, Manning L, Phuanukoonnon S, Harino P, Chambers ST. The scent of Mycobacterium tuberculosis – part II breath. Tuberculosis (Edinb.) 89, 263–266 (2009).
  Medline CASGoogle Scholar
• 53 Peled N, Ionescu R, Nol P et al. Detection of volatile organic compounds in cattle naturally infected with Mycobacterium bovis. Sens. Actuat. B 171, 588–594 (2012).
  Google Scholar
• 54 Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 62, 10–29 (2012).
  MedlineGoogle Scholar
• 55 Barash O, Peled N, Hirsch FR, Haick H. Sniffing the unique ‘odor print’ of non-small-cell lung cancer with gold nanoparticles. Small 5, 2618–2624 (2009).
  Medline CASGoogle Scholar
• 56 Barash O, Peled N, Tisch U, Bunn PA, Hirsch FR, Haick H. Classification of the lung cancer histology by gold nanoparticle sensors. Nanomedicine 8, 580–589 (2012).
  Medline CASGoogle Scholar
• 57 Argiris A, Karamouzis MV, Raben D, Ferris RL. Head and neck cancer. Lancet 371(9625), 1695–1709 (2008).
  Medline CASGoogle Scholar
• 58 Hakim M, Billan S, Tisch U et al. Diagnosis of head and neck cancer from exhaled breath. Br. J. Cancer 104, 1649–1655 (2011).
  Medline CASGoogle Scholar
• 59 Gruber M, Tisch U, Jeries R et al. Analysis of exhaled breath for diagnosing head and neck squamous cell carcinoma: a feasibility study. Br. J. Cancer 111 790–798 (2014).
  Medline CASGoogle Scholar
• 60 Guray M, Sahin AA. Benign breast diseases: classification, diagnosis, and management. Oncologist 11, 435–449 (2006).
  MedlineGoogle Scholar
• 61 Shuster G, Gallimidi Z, Reiss AH et al. Classification of breast cancer precursors through exhaled breath. Breast Cancer Res. Treat. 126, 791–796 (2011).
  MedlineGoogle Scholar